[ad_1]
Doctors working in health centers will be vaccinated first. In the second phase, vaccines will be administered to staff and patients in treatment facilities that provide supportive care and nursing care. These groups should be vaccinated during the first quarter of the year. Later, after vaccinating the priority groups, we will invite the public to get vaccinated.
The specialists of the Ministry of Health (SAM) periodically consult with the European Commission to guarantee the proper functioning of the vaccination mechanism. The first shipment of vaccines will be distributed to hospitals in Vilnius, Kaunas, Klaipėda, Šiauliai and Panevėžys.
Municipalities are used for the second stage of vaccination. The directors of the municipal administrations have appointed a coordinator, a municipal doctor or another member of the administrative staff, who will coordinate the vaccination process in a particular municipality and the personal health establishments that will organize the vaccination of priority groups.
Designated coordinators will organize coronavirus vaccination at their municipalities’ treatment facilities. To ensure smooth vaccination of the population, SAM experts will work closely with coordinators.
The European Medicines Agency (EMA) is currently examining the registration applications of two vaccine manufacturers: BioNTech & Pfizer and Moderna. The evaluation of the BioNTech & Pfizer vaccine has now entered its final stage. After evaluating the quality, efficacy, and possible side effects of the vaccine, EMA experts have already given a positive conclusion for the approval of the BioNTech & Pfizer vaccine. The vaccine is scheduled for approval tomorrow.
If the European Medicines Agency decides that the vaccines meet the requirements for safety and efficacy, the European Commission will register the medicine and allow its use in all countries of the European Union.
[ad_2]
